Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction - PRESENT HF Study

NCT05487261 is registered in ClinicalTrials.gov with Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań as lead sponsor.

NCT NCT05487261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction - PRESENT HF Study
Lead sponsor
Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań
Phase
Phase 4
Overall status
Unknown status
Start date
December 13, 2022
Completion date
November 30, 2025
Enrollment
260 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure